Position
Chief Science Officer
Company
Voyageur Pharmaceuticals
CalgaryManufacturingBiotechnologyPharmaceuticalDescription
Voyageur Pharmaceuticals Ltd proudly announces the appointment of Dr Iryna Saranchova MD, PhD, as its new Chief Science Officer (CSO), pending regulatory approval. Dr Saranchova, a distinguished expert in clinical research and immunology, brings a wealth of experience that will further accelerate the Company’s scientific endeavors.
Quick answer
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer (September 18, 2024). Voyageur Pharmaceuticals is based in Calgary, Alberta, Canada.
- Who is the new Chief Science Officer at Voyageur Pharmaceuticals?
- Voyageur Pharmaceuticals named Iryna Saranchova Chief Science Officer, announced September 18, 2024.
- What did Voyageur Pharmaceuticals announce on September 18, 2024?
- Voyageur Pharmaceuticals Ltd proudly announces the appointment of Dr Iryna Saranchova MD, PhD, as its new Chief Science Officer (CSO), pending regulatory approval. Dr Saranchova, a distinguished expert in clinical research and immunology, brings a wealth of experience that will further accelerate the Company’s scientific endeavors.
- What does Voyageur Pharmaceuticals do?
- Voyageur Pharmaceuticals Ltd. is a Canadian public company trading under the symbol VM on the TSXV, focusing on developing barium and iodine Active Pharmaceutical Ingredients (API) and offering high-performance,...
- Where is Voyageur Pharmaceuticals based?
- Voyageur Pharmaceuticals is based in Calgary, Alberta, Canada.
- Which similar companies made leadership changes around the same time?
- Eli Lilly and Company (September 9, 2024), Cipher Pharmaceuticals (October 8, 2024), Akums Drugs and Pharmaceuticals (August 26, 2024) and Bora Pharmaceuticals Ltd (October 15, 2024) also announced leadership changes within 45 days of Voyageur Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Eli Lilly and Company Appoints Lucas Montarce as Executive Vice President and CFO (September 9, 2024)
- Cipher Pharmaceuticals Appoints Hamed Ghanei as Chief Business Officer (October 8, 2024)
- Akums Drugs and Pharmaceuticals Limited Appoints Amrut Medhekar as Chief Executive Officer - CDMO Business (August 26, 2024)
- Bora Pharmaceuticals appoints J.D. Mowery as Division President to drive growth and innovation in the global CDMO sector (October 15, 2024)
- Cipla Limited Appoints Maya Hari as CEO and Sharmila Paranjpe as CFO (October 17, 2024)
- Fennec Pharmaceuticals Appoints Pierre S. Sayad as Chief Medical Officer and Terry Evans as Chief Commercial Officer; Christiana Cioffi, MBA, Named Chief Strategy Officer (October 28, 2024)
Who to call at Voyageur Pharmaceuticals, and when
A new leader at Voyageur Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Voyageur Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Voyageur Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Voyageur Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Voyageur Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Voyageur Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.